The global Jet Lag Therapy Market will be worth USD 548.5 million by 2027, according to a current analysis by Emergen Research. Jet lag symptoms cause a wide variety of considerable health hazards to athletes, business executives and seasonal travelers, affecting a wide range of people which is around 1 billion annually.
The report is updated with the latest economic scenario and market scope with regard to the ongoing COVID-19 pandemic. The report covers growth prospects as well as current and futuristic revenue estimations in a post COVID scenario. The report also covers changing trends and market dynamics due to the pandemic and provides an accurate impact analysis of the crisis on the overall market.
The primary factors which are attributing to the growth of the jetlag therapy market are: growing elderly population, and rising incidence and prevalence rate of circadian rhythm related issues like tiredness, sleep disorders and winter blues. Moreover, high rate of awareness concerning advanced light therapy and treatment with minimum side-effects is anticipated to drive the growth of medical devices product like wearable light-weight medical care devices.
Get a sample of the report : https://www.emergenresearch.com/request-sample/190
For the purpose of this report, Emergen Research has segmented into the global Jet Lag Therapy Market on the product, distribution channel, end user and region:
Product Outlook (Revenue, USD Billion; 2017-2027)
- Prescription Drugs
- Melatonin
- Herbal and Natural Products
- Medical Devices
- Others
Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)
- Over the Counter
- Online
End User Outlook (Revenue, USD Billion; 2017-2027)
- Business Travelers
- Cabin Crew
- Athletes
- Seasonal Travelers
- Others
Key Highlights From The Report.
In July 2019, Vanda Pharmaceuticals received the FDA approval as a part of its ongoing review of Vanda's supplemental New Drug Application (sNDA) for HETLIOZ® (tasimelteon). The drug was developed in order to treat Jet Lag Disorder especially for eastward trans-meridian travelers.
The medical devices segment, especially the wearable devices has been gaining traction over the years and is likely to grow at a CAGR of 3.9% over the forecast period. This can be attributed to the fact that wearable devices are versatile in nature (in terms of relevance and portability) and are majorly preferred by athletes. attributable to their advancements inside the essential style, thereby, giving a good vary of choices for numerous end-user teams. Furthermore, products like Neuroon, Re-Timer conjointly demonstrates a formidable growth and is expected to continue growing in the future, with growing awareness and emergence of jetlag therapy market across developed countries like US and Japan.
Request a discount on the report : https://www.emergenresearch.com/request-discount/190
The cabin crew segment is poised to grow considerably at a CAGR of 4.3% throughout the forecasted period. The latest commercial aircrafts cross time zones at nearly the same rate as the earth rotates, and it is the result of these trans-meridian transitions that ultimately leads to the rapid time zone change syndrome also known as jet lag. Jet lag may often lead to short-term memory and poor decision-making; thereby affecting the overall functioning of the cabin crew, if neglected constantly. To cater to the problem, major airlines throughout the globe are trying to find viable solutions for jet lag, by exploring new forms of solutions for managing the passengers’ as well as their employees’ alertness levels.
Key participants include Ayo (Novalogy), Lumie, Lucimed S.A., The Litebook Company Ltd., Northern Light Technologies, Nature Bright, Re-Time Pty Ltd., and Chrono Eyewear BV. among others.
The incidence rate of jet-lag across the globe continues to be unknown, however it impacts a high proportion of around 31 million travelers who depart from the U.S. on a yearly basis for destinations that cross 5 or more number of zones. The effects of jetlag span over a 100 million people annually across the globe.
TOC of the global Jet Lag Therapy market report:
Chapter 1, describes the Jet Lag Therapy Introduction, market overview, product offerings, growth opportunities, market risks, driving forces, and challenges.
Chapter 2, analyzes the key manufacturers of Jet Lag Therapy , along with the sales, revenue, and price of Jet Lag Therapy , in the forecast period.
Chapter 3, studies the competitive situation among the major manufacturers and vendors, with sales, revenue, and market share.
Chapter 4, analyzes the global market by regions, with sales, revenue, and market share of Jet Lag Therapy , for each region, from 2020 to 2027.
Chapters 5, 6, 7, 8 and 9, analyze the Jet Lag Therapy market by type, application, regions, and manufacturers, with sales, revenue, and market share by key countries in these regions…Continued
Read More: https://www.emergenresearch.com/industry-report/jet-lag-therapy-market
Related reports:
automated breast ultrasound market
drug discovery services market
flexible sigmoidoscopy market
hydralazine market
https://www.google.it.ao/url?q=https://www.emergenresearch.com/industry-report/hydralazine-market
retinal imaging market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Facebook | LinkdIn | Twitter | Blogs
